Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung and Gut Microbiome in COPD
Efstathios Karakasidis, Ourania S. Kotsiou, Konstantinos I. Gourgoulianis
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 804-804
Open Access | Times Cited: 14

Showing 14 citing articles:

Approach to the diagnosis and management of dysbiosis
Kannayiram Alagiakrishnan, Joao Morgadinho, Tyler Halverson
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 11
Dietary Fiber‐Derived Microbial Butyrate Suppresses ILC2‐Dependent Airway Inflammation in COPD
Min Jiang, Jing Wang, Zheng Li, et al.
Mediators of Inflammation (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 5
Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders
Sumel Ashique, Neeraj Mishra, Shubhrajit Mantry, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5
The Role of Inflammation in the Pathogenesis of Comorbidity of Chronic Obstructive Pulmonary Disease and Pulmonary Tuberculosis
Stanislav Kotlyarov, Д. Н. Оськин
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2378-2378
Open Access
Fungal microbiota in COPD patients during exacerbations
Weronika Gawor, Katarzyna Góralska, Sandra Galant, et al.
Journal de Mycologie Médicale (2025) Vol. 35, Iss. 2, pp. 101543-101543
Closed Access
The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs
Megan O’Shaughnessy, Orla Sheils, Anne‐Marie Baird
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12296-12296
Open Access | Times Cited: 9
Deciphering the impact of microbial interactions on COPD exacerbation: An in-depth analysis of the lung microbiome
Hamidreza Taherkhani, Azadeh KavianFar, Sargol Aminnezhad, et al.
Heliyon (2024) Vol. 10, Iss. 4, pp. e24775-e24775
Open Access | Times Cited: 2
Normal human microbiota and dysbiosis: Implications for health and disease
Dragana D. Božić, Marina Milenković, Jelena Antić‐Stanković, et al.
Arhiv za farmaciju (2024) Vol. 74, Iss. 3, pp. 1-22
Open Access | Times Cited: 1
The impact of Sangju Qingjie Decoction on the pulmonary microbiota in the prevention and treatment of chronic obstructive pulmonary disease
Zheng Liu, Ying Huang, Chao Hu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 1
Gut Microbiota Modulation in the Management of Chronic Obstructive Pulmonary Disease: A Literature Review
Srihita Patibandla, Nilay Bhatt, Sean Lief, et al.
Cureus (2024)
Open Access | Times Cited: 1
Polygala Tenuifolia Willd Water Extract Delays the Progression of Cigarette Smoke-Induced Copd in Mice by Inhibiting Pulmonary Inflammation and Remodeling Gut Microbiota Homeostasis
Yiming An, Chao Wang, Xiao Yu, et al.
(2024)
Closed Access
Lung Microbiome in Lung Cancer: A Systematic Review
Sergiu-Remus Lucaciu, Bianca Domokos Hancu, Ruxandra Puiu, et al.
Microorganisms (2024) Vol. 12, Iss. 12, pp. 2439-2439
Open Access
Dynamic microbial changes in exacerbation of chronic obstructive pulmonary disease
Yong Jun Choi, Hye Jung Park, Ha Eun Kim, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access
COPD and Immune Checkpoint Inhibitors for Cancer: A Literature Review
Thomas Lycan, D. Norton, Jill Ohar
International Journal of COPD (2024) Vol. Volume 19, pp. 2689-2703
Open Access
Page 1

Scroll to top